TrialAlzheimer's & dementia : the journal of the Alzheimer's Association2026

Dulaglutide and neurodegeneration biomarkers: REWIND post hoc analysis.

Jonathan M Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.